Filing Details
- Accession Number:
- 0001127602-14-022634
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-07-02 17:21:57
- Reporting Period:
- 2014-07-01
- Filing Date:
- 2014-07-02
- Accepted Time:
- 2014-07-02 17:21:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1520262 | Alkermes Plc. | ALKS | Pharmaceutical Preparations (2834) | 981007018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1376545 | G Gordon Pugh | 852 Winter St. Waltham MA 02451 | Svp, Coo & Cro, Alkermes, Inc. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2014-07-01 | 5,794 | $15.95 | 61,571 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2014-07-01 | 10,206 | $14.13 | 71,777 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2014-07-01 | 13,900 | $51.16 | 57,877 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2014-07-01 | 2,100 | $15.57 | 55,777 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Non Qualified Stock Option (Right to Buy) | Disposition | 2014-07-01 | 5,794 | $0.00 | 5,794 | $15.95 |
| Ordinary Shares | Employee Stock Option (Right to Buy) | Disposition | 2014-07-01 | 10,206 | $0.00 | 10,206 | $14.13 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-06-01 | No | 4 | M | Direct | |
| 4,794 | 2017-11-05 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Ordinary Shares | 5,000 | Indirect | Gordon G. Pugh Revocable Trust - 2012 |
| Ordinary Shares | 15,000 | Indirect | Nancy E. Pugh Revocable Trust - 2012 |
Footnotes
- This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.52 to $51.52. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.53 to $51.64. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- These options are fully vested in accordance with their terms.
- 75% vested as of 9/16/11, remainder vests on 11/5/11.
Billionaire Hedge Funds
